Pharmaceuticals

  1. 19 Sep 2018  |  North America  |  Market Research

    Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022

    Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics

    The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...

    $4,950.00
  2. 24 Apr 2018  |  North America  |  Market Research

    Growth Insights—Real World Evidence Analytics Solutions Market

    Innovation and Changing End-user Needs Driving Market Growth

    Over the last 3-5 years, growing cost pressure on healthcare and pharmaceutical companies and a significant shift towards outcome based healthcare approach have resulted in companies increasingly adopting real world data and evidence solutions to optimize their operation and cost using analytics. Earlier, applications of RWE were largely limited to...

    $3,000.00
  3. 12 Apr 2018  |  Europe  |  Market Research

    Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action

    Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth

    The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

    $3,000.00
  4. 20 Nov 2017  |  North America  |  Market Research

    Global Biologics Market—Companies-to-Action

    Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development

    This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...

    $3,000.00
  5. 27 Sep 2017  |  Africa  |  Market Research

    East African Pharmaceutical Market, Forecast to 2021

    Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

    Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

    $4,950.00
  6. 19 Apr 2017  |  Asia Pacific  |  Market Research

    Global CRO Market, Forecast to 2021

    The Global CRO Market to Reach $64.58 Billion by 2021

    The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...

    $4,950.00
  7. 02 Mar 2017  |  Global  |  Technology Research

    Biomarkers Enabling Diabetes and Obesity Management

    Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management

    Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...

    $4,950.00
  8. 16 Aug 2016  |  North America  |  Market Research

    Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

    Emerging Business Models Drive Transformation

    The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to c...

    $7,000.00
  9. 31 May 2016  |  Asia Pacific  |  Market Research

    2016 Indonesia Transformational Health Insights

    Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage

    Indonesia is expected to see a substantial rise in healthcare spending driven by rapid urbanization, a growing middle class population, and an increasing prevalence of chronic diseases. Government initiatives to provide universal healthcare coverage (UHC) by 2019 are one of the key reasons for making Indonesia an attractive healthcare market. All t...

    $1,500.00
  10. 27 May 2016  |  Africa  |  Market Research

    Pharmaceutical Market Access Strategy for Ethiopia

    Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain

    Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...

    $4,950.00